Health hazard evaluation report: HETA-98-0048-2688, the Children's Hospital, Denver, Colorado.
NIOSH 1998 Apr; :1-26
In response to a request from Denver's Children's Hospital management, the National Institute for Occupational Safety and Health (NIOSH) conducted an industrial hygiene evaluation of health care worker's exposures to aerosolized ribavirin. Rivabirin is a synthetic nucleoside that is used to prevent and treat respiratory syncytial virus (RSV) infections in infants and children. The specific request was for NIOSH to evaluate exposures to ribavirin and determine if N-95 disposable respirators should be used to provide supplemental protection against exposure to the drug. At Children's Hospital, ribavirin is frequently administered through the Airlife face mask enclosed by an aerosol scavenging system (a NOVA Tenthouse cube attached to the hospital's suction system).
Region-8; Hazard-Unconfirmed; Health-hazard-evaluation; Hospitals; Ribavivrin; Nucleosides; Respirators; Industrial-hygiene; Exposures; Air-sampling;
Author Keywords: General Medical and Surgical Hospitals; ribavirin; VirazoleŽ; 1-beta-D-ribofuranosyl- 1,2,4-triazole-3-carboximide; aerosolized drugs; aerosolized pharmaceuticals; health care workers; aerosol containment system
Field Studies; Hazard Evaluation and Technical Assistan
NTIS Accession No.
National Inst. for Occupational Safety and Health, Cincinnati, OH. Div. of Surveillance, Hazard Evaluations and Field Studies